Shanghai Henlius Biotech, Inc. Financials

Market Capitalization HK$30.38 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	33.88
Forward PE	37.27
Price to Sales TTM	HK$5.31
Price to Book MRQ	HK$10.08
Enterprise to Revenue	5.51
Enterprise to EBITDA	27.14

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2023-12-31
Profit Margin	14.33%
Operating Margin	14.05%
Return on Assets TTM	5.28%
Return on Equity TTM	31.52%

Income Statement

Revenue TTM	HK$6,265,981,621
Revenue per Share TTM	HK$10.53
Quarterly Revenue Growth	1.50%
Gross Profit TTM	HK$4,580,531,042
EBITDA	HK$1,338,724,000
Net Income to Common TTM	HK$898,086,479
Diluted EPS TTM	HK$1.65
Quarterly Earnings Growth YoY	57.10%

Balance Sheet

Total Cash MRQ	HK$890,711,012
Total Cash per Share MRQ	HK$1.50
Total Debt MRQ	HK$
Total Debt to Equity MRQ	121.06
Current Ratio MRQ	0.50
Book Value per Share MRQ	HK$5.55

Cash Flow

Operating Cash Flow TTM	HK$1,359,369,483
Levered Free Cash Flow TTM	HK$193,370,249

2696 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	543,494,853
Float Shares	84,160,178
Avg 10 Volume	1,637,997
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	51.34%
% Held by Institutions	14.72%

Stock Price Summary

Beta	0.82
Fifty Two Week Low	HK$15.20
Fifty Two Week High	HK$56.20
Fifty Two Week Change	59.12%
Day 50 MA	HK$44.31
Day 200 MA	HK$28.88

Dividends and Splits

Forward Annual Dividend Rate	HK$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	HK$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date